WAM
CRSP icon

Werlinich Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Werlinich Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,485
Closed -$726K – 58
2021
Q3 		$726K Sell
6,485
-185
-3% -$20.7K 0.59% 50
2021
Q2 		$1.08M Buy
6,670
+290
+5% +$46.9K 0.87% 38
2021
Q1 		$777K Buy
+6,380
New +$777K 0.68% 47